YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations

Aug.10.2022
YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations
YOOZ builds a comprehensive lab to promote research and innovation for electronic cigarettes, prioritizing quality and safety.

Starting from May 1, 2022, the mandatory national standard for electronic cigarettes was approved by the State Administration for Market Regulation and the National Standardization Management Committee. The "Regulations on the Management of Electronic Cigarettes" issued by the State Tobacco Monopoly Administration will also come into effect. The orderly implementation of the national standard and regulations not only marks the formal entry of the electronic cigarette industry into a phase with legal compliance, but also serves as a driving force for guiding electronic cigarette companies to gradually develop in the direction of scientific research and innovation. In order to better implement regulatory requirements and promote comprehensive innovation in the industry through scientific and technological innovation, YOOZ, a leading electronic cigarette company, has recently publicly launched a comprehensive laboratory built around CNAS standards.


In response, YOOZ, a department related to the company, stated that the implementation of both the national standard for electronic cigarettes and the new regulations is a boost for the long-term development of the industry. YOOZ has consistently relied on scientific research to support a more sustainable industry development strategy. This is both a responsibility and a necessary attitude for electronic cigarette companies to maintain a stable development trajectory.


With meticulous analysis, we always adhere to the principle of "customer first.


As we all know, consumers' greatest concerns always revolve around product quality and safety. Electronic cigarettes, which are often thought to have a low technological threshold, are at risk of having their quality and safety overlooked. However, the lower the technological threshold of a product, the greater the need for safety production and compliance. Prior to regulations being enforced, the electronic cigarette market was filled with various generic and fake products. Guarding consumer safety has become one of the crucial issues in the development of the industry. As a leading enterprise in the industry, YOOZ has always upheld the principle of "putting users first" and continuously strives to protect consumer rights.


Although e-cigarettes are often mocked as low-tech products, every production process and component must go through a rigorous and safe production process to prevent products with quality defects from entering the market. YOOZ's laboratory took half a year to prepare and put into use, and was built in accordance with CNAS standards. The testing center mainly consists of a physical laboratory, a chemical laboratory, an electrical laboratory, and an environmental laboratory, with more than 70 instruments and the ability to conduct over 100 standardized tests. YOOZ has a standardized testing method and strict quality management system in place for quality control and testing, thoroughly evaluating product performance, reliability, and safety throughout the product development process.


YOOZ Citrus Detection Center has developed simulated artificial smoking detection devices that mimic users' daily habits to provide more accurate experiences. Additionally, these devices help the company develop products that meet the needs of different users and provide more options. In addition, the batteries used in YOOZ products undergo over 400 cycles of charge and discharge in a longevity laboratory, as well as safety performance testing under various extreme conditions. This ensures that the product has good performance when frequently used by users.


It is noteworthy that the YOOZ Lemon Lab has taken the initiative to add a waterproof test in accordance with the National Standard for Electronic Cigarettes and the Measures for the Administration of Electronic Cigarettes. This demonstrates YOOZ Lemon's determination and implementation speed in compliance development, as well as their effort to improve and meet national standard requirements.


Moving towards research-oriented businesses is the development goal and mission of electronic cigarette companies.


YOOZ Laboratory not only bears the responsibility of safety and innovation, but also serves as a central hub that connects and streamlines the upstream and downstream industries. For businesses, the laboratory takes control of both research and production standards, leading to a more selective and high-quality choice of suppliers through strict requirements. This stimulates the development of the supply chain by reversing the stimulating effect of R&D capabilities, resulting in the production of safer, more environmentally friendly, and more cost-effective products that fully satisfy consumers' needs.


In the future, YOOZ will continue to prioritize consumer satisfaction and aim for long-term growth. They will spare no effort in ensuring compliance, safety, scientific research, innovation, and environmental friendliness, serving as a model for industry leaders. They will actively recruit talent and use their technological capabilities to push forward the development of the electronic cigarette industry, bringing more value to the industry's progress.


This article contains excerpts or reprints of third-party information, and the copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual that needs to reprint, please contact the author and do not repost directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
A meeting was held at the Department for Combating Economic Crimes under the General Prosecutor’s Office of Uzbekistan with representatives of British American Tobacco Uzbekistan. Participants included the department’s leadership, the Inspectorate for Regulation of the Alcohol and Tobacco Market, and business representatives.
May.09 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium’s federal government on Thursday approved a ban on flavored vapes, allowing only tobacco-flavored and unflavored e-cigarettes on the market from September 2028. Health Minister Frank Vandenbroucke said the measure is aimed at protecting the health of children and young people and preventing a new generation from becoming dependent on tobacco.
May.06 by 2FIRSTS.ai
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
Australian One Nation leader Pauline Hanson has proposed cutting tobacco excise by 50% and freezing indexation until June 30, 2028, in a bid to lower legal cigarette prices and reduce the price advantage of the illicit tobacco market.
Jun.18